Form D · Other Technology
PHIGENIX, INC.
Atlanta, GA · CIK 0001432120
Offering snapshot reported Aug 19, 2015 · SEC filing
- Reported sold
- $842K Offering amount: $10.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $35K Reported outside-investor minimum
- First sale
- Sep 1, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2015 | Initial | $842,400 | No comparison | 14 | SEC filing |
| Aug 21, 2014 | Amendment | $3,722,463 | No comparison | 78 | SEC filing |
| Apr 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-246064
Source: Form D, filed Aug 19, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cynthia N. Day | Director |
| Wennifer H. Donald | Director, Executive |
| Carlton D. Donald, Ph.D | Director, Executive |
| Kenneth E. Robinson, M.D. | Director |
| Richard A. Roy, M.D. | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
191 Peachtreet Street, N.E. Suite 3200
Atlanta, GA, 30303
Atlanta, GA, 30303